Cargando…

Improved Peptide Backbone Fragmentation Is the Primary Advantage of MS-Cleavable Crosslinkers

[Image: see text] Proteome-wide crosslinking mass spectrometry studies have coincided with the advent of mass spectrometry (MS)-cleavable crosslinkers that can reveal the individual masses of the two crosslinked peptides. However, recently, such studies have also been published with noncleavable cro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolbowski, Lars, Lenz, Swantje, Fischer, Lutz, Sinn, Ludwig R., O’Reilly, Francis J., Rappsilber, Juri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178559/
https://www.ncbi.nlm.nih.gov/pubmed/35613060
http://dx.doi.org/10.1021/acs.analchem.1c05266
_version_ 1784723084850233344
author Kolbowski, Lars
Lenz, Swantje
Fischer, Lutz
Sinn, Ludwig R.
O’Reilly, Francis J.
Rappsilber, Juri
author_facet Kolbowski, Lars
Lenz, Swantje
Fischer, Lutz
Sinn, Ludwig R.
O’Reilly, Francis J.
Rappsilber, Juri
author_sort Kolbowski, Lars
collection PubMed
description [Image: see text] Proteome-wide crosslinking mass spectrometry studies have coincided with the advent of mass spectrometry (MS)-cleavable crosslinkers that can reveal the individual masses of the two crosslinked peptides. However, recently, such studies have also been published with noncleavable crosslinkers, suggesting that MS-cleavability is not essential. We therefore examined in detail the advantages and disadvantages of using the commonly used MS-cleavable crosslinker, disuccinimidyl sulfoxide (DSSO). Indeed, DSSO gave rise to signature peptide fragments with a distinct mass difference (doublet) for nearly all identified crosslinked peptides. Surprisingly, we could show that it was not these peptide masses that proved the main advantage of MS cleavability of the crosslinker, but improved peptide backbone fragmentation which reduces the ambiguity of peptide identifications. This also holds true for another commonly used MS-cleavable crosslinker, DSBU. We show furthermore that the more intricate MS3-based data acquisition approaches lack sensitivity and specificity, causing them to be outperformed by the simpler and faster stepped higher-energy collisional dissociation (HCD) method. This understanding will guide future developments and applications of proteome-wide crosslinking mass spectrometry.
format Online
Article
Text
id pubmed-9178559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-91785592022-06-10 Improved Peptide Backbone Fragmentation Is the Primary Advantage of MS-Cleavable Crosslinkers Kolbowski, Lars Lenz, Swantje Fischer, Lutz Sinn, Ludwig R. O’Reilly, Francis J. Rappsilber, Juri Anal Chem [Image: see text] Proteome-wide crosslinking mass spectrometry studies have coincided with the advent of mass spectrometry (MS)-cleavable crosslinkers that can reveal the individual masses of the two crosslinked peptides. However, recently, such studies have also been published with noncleavable crosslinkers, suggesting that MS-cleavability is not essential. We therefore examined in detail the advantages and disadvantages of using the commonly used MS-cleavable crosslinker, disuccinimidyl sulfoxide (DSSO). Indeed, DSSO gave rise to signature peptide fragments with a distinct mass difference (doublet) for nearly all identified crosslinked peptides. Surprisingly, we could show that it was not these peptide masses that proved the main advantage of MS cleavability of the crosslinker, but improved peptide backbone fragmentation which reduces the ambiguity of peptide identifications. This also holds true for another commonly used MS-cleavable crosslinker, DSBU. We show furthermore that the more intricate MS3-based data acquisition approaches lack sensitivity and specificity, causing them to be outperformed by the simpler and faster stepped higher-energy collisional dissociation (HCD) method. This understanding will guide future developments and applications of proteome-wide crosslinking mass spectrometry. American Chemical Society 2022-05-25 2022-06-07 /pmc/articles/PMC9178559/ /pubmed/35613060 http://dx.doi.org/10.1021/acs.analchem.1c05266 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Kolbowski, Lars
Lenz, Swantje
Fischer, Lutz
Sinn, Ludwig R.
O’Reilly, Francis J.
Rappsilber, Juri
Improved Peptide Backbone Fragmentation Is the Primary Advantage of MS-Cleavable Crosslinkers
title Improved Peptide Backbone Fragmentation Is the Primary Advantage of MS-Cleavable Crosslinkers
title_full Improved Peptide Backbone Fragmentation Is the Primary Advantage of MS-Cleavable Crosslinkers
title_fullStr Improved Peptide Backbone Fragmentation Is the Primary Advantage of MS-Cleavable Crosslinkers
title_full_unstemmed Improved Peptide Backbone Fragmentation Is the Primary Advantage of MS-Cleavable Crosslinkers
title_short Improved Peptide Backbone Fragmentation Is the Primary Advantage of MS-Cleavable Crosslinkers
title_sort improved peptide backbone fragmentation is the primary advantage of ms-cleavable crosslinkers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178559/
https://www.ncbi.nlm.nih.gov/pubmed/35613060
http://dx.doi.org/10.1021/acs.analchem.1c05266
work_keys_str_mv AT kolbowskilars improvedpeptidebackbonefragmentationistheprimaryadvantageofmscleavablecrosslinkers
AT lenzswantje improvedpeptidebackbonefragmentationistheprimaryadvantageofmscleavablecrosslinkers
AT fischerlutz improvedpeptidebackbonefragmentationistheprimaryadvantageofmscleavablecrosslinkers
AT sinnludwigr improvedpeptidebackbonefragmentationistheprimaryadvantageofmscleavablecrosslinkers
AT oreillyfrancisj improvedpeptidebackbonefragmentationistheprimaryadvantageofmscleavablecrosslinkers
AT rappsilberjuri improvedpeptidebackbonefragmentationistheprimaryadvantageofmscleavablecrosslinkers